Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominik Wolf

Showing results (311-320 of 331) with videos related to

Pageof 34
Sort By:
Journal of Hematology & Oncology|April 3, 2023
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registryFrancesco Marchesi, Jon Salmanton-García, Caterina Buquicchio, et al.
Nature Communications|August 30, 2024
Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfateElena Ethel Vidal-Calvo, Anne Martin-Salazar, Swati Choudhary, et al.
Cancer Cell|January 13, 2026
Single-cell integration and multi-modal profiling reveals phenotypes and spatial organization of neutrophils in colorectal cancerValentin Marteau, Niloofar Nemati, Kristina Handler, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 1, 2014
The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: evidence of validityGiovanni B Frisoni, Clifford R Jack, Martina Bocchetta, et al.
Blood Advances|April 14, 2023
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA surveyJaap A van Doesum, Jon Salmanton-García, Francesco Marchesi, et al.
Therapeutic Advances in Hematology|March 16, 2023
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registryMonia Marchetti, Jon Salmanton-García, Shaimaa El-Ashwah, et al.
International Journal of Antimicrobial Agents|August 15, 2023
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registryJon Salmanton-García, Francesco Marchesi, Philipp Koehler, et al.
American Journal of Hematology|June 15, 2022
Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey reportOla Blennow, Jon Salmanton-García, Piotr Nowak, et al.
Cancer Discovery|October 12, 2021
Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional RespondersChristoph Kornauth, Tea Pemovska, Gregory I Vladimer, et al.
Open Forum Infectious Diseases|March 19, 2026
Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA RegistryJon Salmanton-García, Francesco Marchesi, Erica Mackenzie, et al.
Pageof 34

Showing results (311-320 of 331) with videos related to

Sort By:
Pageof 34
Journal of Hematology & Oncology|April 3, 2023
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registryFrancesco Marchesi, Jon Salmanton-García, Caterina Buquicchio, et al.
Nature Communications|August 30, 2024
Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfateElena Ethel Vidal-Calvo, Anne Martin-Salazar, Swati Choudhary, et al.
Cancer Cell|January 13, 2026
Single-cell integration and multi-modal profiling reveals phenotypes and spatial organization of neutrophils in colorectal cancerValentin Marteau, Niloofar Nemati, Kristina Handler, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 1, 2014
The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: evidence of validityGiovanni B Frisoni, Clifford R Jack, Martina Bocchetta, et al.
Blood Advances|April 14, 2023
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA surveyJaap A van Doesum, Jon Salmanton-García, Francesco Marchesi, et al.
Therapeutic Advances in Hematology|March 16, 2023
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registryMonia Marchetti, Jon Salmanton-García, Shaimaa El-Ashwah, et al.
International Journal of Antimicrobial Agents|August 15, 2023
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registryJon Salmanton-García, Francesco Marchesi, Philipp Koehler, et al.
American Journal of Hematology|June 15, 2022
Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey reportOla Blennow, Jon Salmanton-García, Piotr Nowak, et al.
Cancer Discovery|October 12, 2021
Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional RespondersChristoph Kornauth, Tea Pemovska, Gregory I Vladimer, et al.
Open Forum Infectious Diseases|March 19, 2026
Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA RegistryJon Salmanton-García, Francesco Marchesi, Erica Mackenzie, et al.
Pageof 34